Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando López-Ríos

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Acta Cytologica|April 12, 2007
Primary papillary serous carcinoma of the peritoneum: report of a case with diagnosis by fine needle aspiration and immunocytochemistryNuria Alberti, Anastasio Serrano-Egea, Elena García-García, et al.
Revista Espanola De Cardiologia|May 31, 2007
[Nonbacterial thrombotic endocarditis: clinicopathologic study of a necropsy series]Jara Llenas-García, Juan M Guerra-Vales, Santiago Montes-Moreno, et al.
Journal of Clinical Pathology|May 10, 2012
HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancerCarlos Gómez-Martin, Elena Garralda, M José Echarri, et al.
Medicina Clinica|April 17, 2009
[Prognostic value study of lung cancer molecular markers]Ricardo García Luján, Esther Conde Gallego, Fernando López Ríos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2012
Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)Pilar Garrido, Javier de Castro, Ángel Concha, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|July 12, 2020
[Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology]Fernando López-Ríos, Luis Paz-Ares, Julián Sanz, et al.
Lung Cancer (Amsterdam, Netherlands)|February 4, 2025
Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancerPaul Hofman, Petros Christopoulos, Nicky D'Haene, et al.
Histopathology|July 21, 2011
Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization methodElena García-García, Carlos Gómez-Martín, Bárbara Angulo, et al.
Cancer Research|October 3, 2007
Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomasFernando López-Ríos, María Sánchez-Aragó, Elena García-García, et al.
Plos One|September 7, 2012
A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistryBárbara Angulo, Esther Conde, Ana Suárez-Gauthier, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Acta Cytologica|April 12, 2007
Primary papillary serous carcinoma of the peritoneum: report of a case with diagnosis by fine needle aspiration and immunocytochemistryNuria Alberti, Anastasio Serrano-Egea, Elena García-García, et al.
Revista Espanola De Cardiologia|May 31, 2007
[Nonbacterial thrombotic endocarditis: clinicopathologic study of a necropsy series]Jara Llenas-García, Juan M Guerra-Vales, Santiago Montes-Moreno, et al.
Journal of Clinical Pathology|May 10, 2012
HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancerCarlos Gómez-Martin, Elena Garralda, M José Echarri, et al.
Medicina Clinica|April 17, 2009
[Prognostic value study of lung cancer molecular markers]Ricardo García Luján, Esther Conde Gallego, Fernando López Ríos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2012
Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)Pilar Garrido, Javier de Castro, Ángel Concha, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|July 12, 2020
[Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology]Fernando López-Ríos, Luis Paz-Ares, Julián Sanz, et al.
Lung Cancer (Amsterdam, Netherlands)|February 4, 2025
Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancerPaul Hofman, Petros Christopoulos, Nicky D'Haene, et al.
Histopathology|July 21, 2011
Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization methodElena García-García, Carlos Gómez-Martín, Bárbara Angulo, et al.
Cancer Research|October 3, 2007
Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomasFernando López-Ríos, María Sánchez-Aragó, Elena García-García, et al.
Plos One|September 7, 2012
A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistryBárbara Angulo, Esther Conde, Ana Suárez-Gauthier, et al.
Pageof 6